| NDC Code | 0093-5215-01 |
|---|
| Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (0093-5215-01) |
|---|
| Product NDC | 0093-5215 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Moexipril Hydrochloride And Hydrochlorothiazide |
|---|
| Non-Proprietary Name | Moexipril Hydrochloride And Hydrochlorothiazide |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20070307 |
|---|
| End Marketing Date | 20191130 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA076980 |
|---|
| Manufacturer | Teva Pharmaceuticals USA, Inc. |
|---|
| Substance Name | MOEXIPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
|---|
| Strength | 15; 25 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
|---|